Malignant vascular tumor

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

Regulatory Watchboard

10 events

Jul 2026Multiple Myeloma t(4 ;14) FFPE Samples

BIWAKO

TrialNOT YET RECRUITING

Jun 2026Multiple Myeloma Extramedulary Disease Samples FFPE

BIWAKO

TrialNOT YET RECRUITING

Mar 2026Pre-malignant States to Hematologic Malignancies in Firefighters

Wake Forest University Health Sciences

TrialRECRUITING

Dec 2025The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Quercis Pharma AG — PHASE3

TrialRECRUITING

Oct 2025Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

IRCCS San Raffaele

TrialNOT YET RECRUITING

Sep 2025Latitude - Lateral Lymph Node Attitude Study

Sahlgrenska University Hospital — NA

TrialNOT YET RECRUITING

Jul 2025A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

BioNTech SE — PHASE1, PHASE2

TrialRECRUITING

Jul 2025Improving Diagnosis and Treatment for Patients With Rectal Cancer

Imperial College London — NA

TrialNOT YET RECRUITING

Apr 2025A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

BioNTech SE — PHASE1, PHASE2

TrialRECRUITING

Apr 2025A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Peking University First Hospital — EARLY_PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Proleukin

Chiron Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Lynparza

(olaparib)Orphan drugstandard

AstraZeneca Pharmaceuticals LP

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

12.1 Mechanism of Action Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are ...

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Malignant vascular tumor.
Search all trials →

Search clinical trials for Malignant vascular tumor →

Recent News & Research

No recent news articles indexed yet for Malignant vascular tumor.
Search PubMed for Malignant vascular tumor →

Browse all Malignant vascular tumor news →

Specialist Network

Top 6 by expertise

Matthew Krebs, Dr

The Christie Hospital

Score 387 trials

Global Clinical Leader

Daiichi Sankyo

Score 3644 trials4 pubs

Nizar M. Tannir, MD, M.D

M.D. Anderson Cancer Center

📍 HOUSTON, TX

Score 203 trials

Lilian T Gien

ECOG-ACRIN Cancer Research Group

Score 182 trials1 pub

BioNTech Responsible Person

BioNTech SE

Score 1318 trials

Premal Lulla, MD, M.D

Baylor College of Medicine

📍 HOUSTON, TX

Score 94 trials

View all Malignant vascular tumor specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles